Promoting Smoking Cessation in the Correctional Institutions

November 18, 2021 updated by: Dr. Wang Man-Ping, The University of Hong Kong

Building Capacity and Promoting Smoking Cessation in the Correctional Institutions

The aim of this project is to promote and evaluate a smoking cessation intervention through the "Quit to Win" Contest organised in correctional institutions in Hong Kong.

The aim of this project is to promote and evaluate a smoking cessation intervention through the "Quit to Win" Contest organised in correctional institutions in Hong Kong. The specific objectives of the study are:

  1. To test the effectiveness of face-to-face brief cessation advice and video education for smoking cessation among current smokers at the correctional institutions in Hong Kong;
  2. To evaluate the process and outcome of the recruitment of smokers through qualitative interviews; and
  3. To conduct qualitative interviews with quitters and non-quitters to examine their experience on the intervention.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

Although smoking prevalence is decreasing in Hong Kong, there are still 615,000 daily cigarette smokers in Hong Kong in 2017 and half will be killed by smoking [5] which accounts for over 7,000 deaths per year. Smoking is a highly addictive behavior and it is difficult for smokers with strong nicotine dependence to quit without assistance. Despite the low smoking rate in the general population, smoking prevalence remain high in the correctional institutions. Incarcerated prisoners suffer disproportionately from mental illness, substance use disorders and disease infections. They are in need of health care such as treatment or prevention for smoking. There is a lack of evidence on the effectiveness of smoking cessation intervention in the correctional setting. More work is required to provide smoking cessation assistance to these high risk and underserved population.

The aim of this project is to promote and evaluate a smoking cessation intervention through the "Quit to Win" Contest organised in correctional institutions in Hong Kong. The specific objectives of the study are:

  1. To test the effectiveness of face-to-face brief cessation advice and video education for smoking cessation among current smokers at the correctional institutions in Hong Kong;
  2. To evaluate the process and outcome of the recruitment of smokers through qualitative interviews; and
  3. To conduct qualitative interviews with quitters and non-quitters to examine their experience on the intervention.

Study Type

Interventional

Enrollment (Anticipated)

140

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hong Kong, Hong Kong
        • School of Nursing, The University of Hong Kong

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Hong Kong residents aged 18 or above
  • Smoke at least 1 cigarette per day in the past 3 months
  • Able to communicate in Cantonese (including reading Chinese)
  • Exhaled carbon monoxide (CO) 4 ppm or above, assessed by a validated CO smokerlyzer
  • Intent to quit / reduce smoking

Exclusion Criteria:

  • Smokers who have difficulties (either physical or cognitive condition) to communicate
  • Currently following other smoking cessation programs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A

CSD participants will receive a combined intervention:

  1. Brief intervention using AWARD advice at baseline,
  2. Video-based health education
Ask about smoking history, Warn about the high risk of smoking, Advise to quit as soon as possible, Refer to the smoking cessation services, and Do it again (if the smokers refused to set quit date)
Educational videos on smoking and health will be developed to improve the knowledge of CSD smokers. The videos aim to raise their awareness on these important health topics and acquire effective cessation methods. The effectiveness of the educational videos will be evaluated by pre- and post-tests through a self-administered survey that assess the changes in knowledge related to smoking hazards, benefits of quitting, and methods to quit smoking.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Biochemical validated quit rate at 6-month follow-up
Time Frame: 6-month follow-up
The primary outcome is biochemically validated quit rates (exhaled CO < 4 ppm and salivary cotinine < 10 ng/ml) at 6-month
6-month follow-up
Biochemical validated quit rate at 3-month follow-up
Time Frame: 3-month follow-up
The primary outcome is biochemically validated quit rates (exhaled CO < 4 ppm and salivary cotinine < 10 ng/ml) at 3-month
3-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Smoking quit rate change from baseline at 3-month follow-up
Time Frame: 3-month follow-up
Self-reported 7-day point prevalence (pp) quit rate at 3-month
3-month follow-up
Smoking quit rate change from baseline at 6-month follow-up
Time Frame: 6-month follow-up
Self-reported 7-day point prevalence (pp) quit rate at 6-month
6-month follow-up
Smoking reduction rate change from baseline at 3-month follow-up
Time Frame: 3-month follow-up
Rate of smoking reduction by at least half of baseline amount
3-month follow-up
Smoking reduction rate change from baseline at 6-month follow-up
Time Frame: 6-month follow-up
Rate of smoking reduction by at least half of baseline amount
6-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 12, 2019

Primary Completion (Anticipated)

June 30, 2022

Study Completion (Anticipated)

December 30, 2022

Study Registration Dates

First Submitted

September 11, 2019

First Submitted That Met QC Criteria

September 11, 2019

First Posted (Actual)

September 13, 2019

Study Record Updates

Last Update Posted (Actual)

December 1, 2021

Last Update Submitted That Met QC Criteria

November 18, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • CSD 2019-2021

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on AWARD advice

3
Subscribe